Andreia Carvalho Pereira

Andreia Carvalho Pereira

Auto-generated profile, based on publicly available information

Andreia Carvalho Pereira

Department of Forensic and Neurodevelopmental Sciences, Institute of Psychiatry, Psychology and Neuroscience, King’s College London, UK

Research Focus & Metrics

Academic Career Length

10Years (2017-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 March 2019 in Progress in Neuro-Psychopharmacology and Biological Psychiatry
Verified
Journal Article
Open access
LALaura A. Ajram
Laura A. Ajram
APAndreia C. Pereira
Andreia C. Pereira
ADAlice M.S. Durieux
Alice M.S. Durieux
HVHester E. Velthius
Hester E. Velthius
MPMarija Magdalena Petrinovic
Marija Magdalena Petrinovic
GMGrainne M. McAlonan
Grainne M. McAlonan
Autism spectrum disorder (ASD) affects over 1:100 of the population and costs the UK more than £32bn and the USA more than $175bn (£104bn) annually. Its core symptoms are social and communication difficulties, repetitive behaviours and sensory hyper- or hypo-sensitivities. A highly diverse phenotypic presentation likely reflects its etiological heterogeneity and makes finding treatment targets for ASD challenging. In addition, there are no means to identify biologically responsive individuals who may benefit from specific interventions. There is hope however, and in this review we consolidate how findings from magnetic resonance spectroscopy (MRS) add to the evidence that differences in the brain's excitatory glutamate and inhibitory γ-aminobutyric acid (GABA) balance may be both a key biomarker and a tractable treatment target in ASD.

1 January 2017 in NeuroImage: Clinical
Verified
Journal Article
Open access
Sónia FerreiraSónia Ferreira
Sónia Ferreira
APAndreia Carvalho Pereira
Andreia Carvalho Pereira
BQBruno Quendera
Bruno Quendera
ARAldina Reis
Aldina Reis
ESEduardo Duarte Silva
Eduardo Duarte Silva
Miguel Castelo-BrancoMiguel Castelo-Branco
Miguel Castelo-Branco
Human studies addressing the long-term effects of peripheral retinal degeneration on visual cortical function and structure are scarce. Here we investigated this question in patients with Retinitis Pigmentosa (RP), a genetic condition leading to peripheral visual degeneration. We acquired functional and anatomical magnetic resonance data from thirteen patients with different levels of visual loss and twenty-two healthy participants to study primary (V1) visual cortical retinotopic remapping and cortical thickness. We identified systematic visual field remapping in the absence of structural changes in the primary visual cortex of RP patients. Remapping consisted in a retinotopic eccentricity shift of central retinal inputs to more peripheral locations in V1. Importantly, this was associated with changes in visual experience, as assessed by the extent of the visual loss, with more constricted visual fields resulting in larger remapping. This pattern of remapping is consistent with expansion or shifting of neuronal receptive fields into the cortical regions with reduced retinal input. These data provide evidence for functional changes in V1 that are dependent on the magnitude of peripheral visual loss in RP, which may be explained by rapid cortical adaptation mechanisms or long-term cortical reorganization. This study highlights the importance of analyzing the retinal determinants of brain functional and structural alterations for future visual restoration approaches.

5 January 2022 in Science Translational Medicine
Verified
Journal Article
Closed access
QHQiyun Huang
Qiyun Huang
APAndreia C. Pereira
Andreia C. Pereira
HVHester Velthuis
Hester Velthuis
NWNichol M. L. Wong
Nichol M. L. Wong
CEClaire L. Ellis
Claire L. Ellis
GMGráinne M. McAlonan
Gráinne M. McAlonan
Differences in GABAergic function are critical to autistic visual sensory neurobiology and can be modulated by targeting GABAB.

24 November 2017 in Journal of Autism and Developmental Disorders
Verified
Journal Article
Closed access
PDF file
APAndreia Carvalho Pereira
Andreia Carvalho Pereira
IVInês R. Violante
Inês R. Violante
SMSusana Mouga
Susana Mouga
GOGuiomar Oliveira
Guiomar Oliveira
Miguel Castelo-BrancoMiguel Castelo-Branco
Miguel Castelo-Branco

12 September 2017 in Scientific Reports
Verified
Journal Article
Open access
PDF file
AMAna Rita Machado
Ana Rita Machado
APAndreia Carvalho Pereira
Andreia Carvalho Pereira
FFFábio Ferreira
Fábio Ferreira
Sónia FerreiraSónia Ferreira
Sónia Ferreira
BQBruno Quendera
Bruno Quendera
Miguel Castelo-BrancoMiguel Castelo-Branco
Miguel Castelo-Branco
Retinitis Pigmentosa is a group of hereditary retinal dystrophy disorders associated with progressive peripheral visual field loss. The impact of this retinal loss in cortical gray matter volume has not been addressed before in Retinitis Pigmentosa patients with low vision. Voxel-based morphometry was applied to study whole brain gray matter volume changes in 27 Retinitis Pigmentosa patients with partially preserved vision and 38 age- and gender-matched normally sighted controls to determine whether peripheral visual loss can lead to changes in gray matter volume. We found significant reductions in gray matter volume that were restricted to the occipital cortex of patients. The anteromedial pattern of reduced gray matter volume in visual primary and association cortices was significantly correlated with the extent of the peripheral visual field deficit in this cohort. Moreover, this pattern was found to be associated with the extent of visual field loss. In summary, we found specific visual cortical gray matter loss in Retinitis Pigmentosa patients associated with their visual function profile. The spatial pattern of gray matter loss is consistent with disuse-driven neuronal atrophy which may have clinical implications for disease management, including prosthetic restoration strategies.

20 September 2022 in Translational Psychiatry
Verified
Journal Article
Open access
PDF file
CCCornelia Carey
Cornelia Carey
NSNisha Singh
Nisha Singh
JDJoel T. Dunn
Joel T. Dunn
TSTeresa Sementa
Teresa Sementa
MMMaria Andreina Mendez
Maria Andreina Mendez
GMGrainne McAlonan
Grainne McAlonan
The metabotropic glutamate receptor 5 (mGluR5) is a key regulator of excitatory (E) glutamate and inhibitory (I) γ-amino butyric acid (GABA) signalling in the brain. Despite the close functional ties between mGluR5 and E/I signalling, no-one has directly examined the relationship between mGluR5 and glutamate or GABA in vivo in the human brain of autistic individuals. We measured [18F] FPEB (18F-3-fluoro-5-[(pyridin-3-yl)ethynyl]benzonitrile) binding in 15 adults (6 with Autism Spectrum Disorder) using two regions of interest, the left dorsomedial prefrontal cortex and a region primarily composed of left striatum and thalamus. These two regions were mapped out using MEGA-PRESS voxels and then superimposed on reconstructed PET images. This allowed for direct comparison between mGluR5, GABA + and Glx. To better understand the molecular underpinnings of our results we used an autoradiography study of mGluR5 in three mouse models associated with ASD:Cntnap2knockout,Shank3knockout, and16p11.2deletion. Autistic individuals had significantly higher [18F] FPEB binding (t(13) = −2.86,p = 0.047) in the left striatum/thalamus region of interest as compared to controls. Within this region, there was a strong negative correlation between GABA + and mGluR5 density across the entire cohort (Pearson’s correlation:r(14) = −0.763,p = 0.002).Cntnap2KO mice had significantly higher mGlu5 receptor binding in the striatum (caudate-putamen) as compared to wild-type (WT) mice (n = 15,p = 0.03). There were no differences in mGluR5 binding for mice with theShank3knockout or16p11.2deletion. Given thatCntnap2is associated with a specific striatal deficit of parvalbumin positive GABA interneurons and ‘autistic’ features, our findings suggest that an increase in mGluR5 in ASD may relate to GABAergic interneuron abnormalities.